Abstract
Hepatic function failed to influence serum concentrations of the antifungal agent 5-fluorocytosine when the drug was given intravenously to rabbits with CCl4-induced hepatic insufficiency or orally to a patient with postnecrotic cirrhosis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Block E. R., Bennett J. E. Pharmacological studies with 5-fluorocytosine. Antimicrob Agents Chemother. 1972 Jun;1(6):476–482. doi: 10.1128/aac.1.6.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koechlin B. A., Rubio F., Palmer S., Gabriel T., Duschinsky R. The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man. Biochem Pharmacol. 1966 Apr;15(4):435–446. doi: 10.1016/0006-2952(66)90254-1. [DOI] [PubMed] [Google Scholar]
- SABESIN S. M., FALLON H. J., ANDRIOLE V. T. Hepatic failure as a manifestation of cryptococcosis. Arch Intern Med. 1963 May;111:661–669. doi: 10.1001/archinte.1963.03620290127018. [DOI] [PubMed] [Google Scholar]
- Vandevelde A. G., Mauceri A. A., Johnson J. E., 3rd 5-fluorocytosine in the treatment of mycotic infections. Ann Intern Med. 1972 Jul;77(1):43–51. doi: 10.7326/0003-4819-77-1-43. [DOI] [PubMed] [Google Scholar]